Are pharma companies pulling their money out of the U.K. because of Trump? And how is biotech M&A pacing this year?

The State Department announced it will refocus its foreign health assistance strategy around multiyear bilateral deals with ...

The Trump administration moved Thursday to shut down a Miami organ donation group, calling it “failing” because of ...

The Senate health committee has invited health secretary Robert F. Kennedy Jr. to testify before the panel amid allegations ...

The chair of a key vaccine committee that advises the CDC will strike a confrontational tone at meeting of the panel, ...

Federal workers send Congress a letter pleading for help, but their trouble attracting signatures reflects fear of ...

The WHO said Thursday that 31 of 38 confirmed Ebola cases have resulted in deaths in southern Congo, where authorities are ...

A Wednesday Senate hearing aimed to answer questions about the exodus of top leaders from the CDC last month. Instead, it ...

Roche is buying 89bio, the maker of an experimental drug for a liver disease that’s attracted major pharma interest, in a ...

ACA enrollees face steep hikes in 2026 as enhanced tax credits expire. Big voting groups, including older adults and small ...

Also, fun note: My dad co-authored a First Opinion article for STAT on the potential impact of AI chatbots on psychosis. But ...

Part of the task facing policymakers, scholars, and commentators will be to reckon with how we got here, vaccine mandate ...